 The ACCEPT study is a Phase IV trial in which women are randomized to either the NuvaRing vaginal contraceptive ring or a low dose oral contraceptive to assess compliance, side effects, overall acceptability and intent to continue use of the method. The study is focused on the acceptability of the vaginal ring among female undergraduate or graduate students. 